A 20/100 patient still has hope that a new safe treatment will come along to help restore vision. The FDA will not risk an unknown treatment at this time.
Not likely for the current Phase 1/2 trial. Unless you have a link, the FDA does not normally change protocol requirements once the trial has begun. The Phase 1/2 is primarily a safety trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.